Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04056312 · ClinicalTrials.gov registry record · NA
Modified Story Memory Technique (mSMT) in Persons With TBI
A NA study, sponsored by Kessler Foundation.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT04056312: Completed NA study, sponsored by Kessler Foundation.
NCT04056312 is a NA study that has completed, run by Kessler Foundation. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04056312, a NA study, has completed, sponsored by Kessler Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The current RCT is designed to: 1. test the efficacy of the group based mSMT in persons with TBI on NPE, the current gold-standard for measuring memory functioning 2. assess the effectiveness of the group mSMT on more global measures of everyday life, including an objective measure shown through our previous work to be sensitive to memory changes following the mSMT, as well as additional questionnaires to be completed by both the participant and a significant other 3. evaluate the changes in brain functioning following treatment with the mSMT via fMRI and 4. evaluate the long-term effects of the treatment protocol. To accomplish these goals investigators will conduct a double-blind, placebo-controlled, RCT, applying the group mSMT to a sample of 60 participants with moderate to severe TBI (30 treatment; 30 control).
Primary Outcome
Change on scores on memory tests will be assessed using the California Verbal Learning Test
Interventions
- BEHAVIORAL Group Memory retraining exercises
- BEHAVIORAL Placebo controlled group memory exercise training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2016-06-29 |
| Est. Completion | 2022-06-30 |
| Phase | NA |
What the finished NCT04056312 record still lists
NCT04056312 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Group Memory retraining exercises is the first listed.
NCT04056312 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04056312 about?
NCT04056312 is a clinical study titled "Modified Story Memory Technique (mSMT) in Persons With TBI". The current RCT is designed to: 1. test the efficacy of the group based mSMT in persons with TBI on NPE, the current gold-standard for measuring memory functioning 2. assess the effectiveness of the group mSMT on more global measures of everyday life, including an objective measure shown through ou...
What is the current status of trial NCT04056312?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2016-06-29. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT04056312?
The interventions under investigation include: Group Memory retraining exercises (BEHAVIORAL), Placebo controlled group memory exercise training (BEHAVIORAL).
Who is sponsoring clinical trial NCT04056312?
This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04056312's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI